Warning: The NCBI web site requires JavaScript to function. more...
Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigò M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F.
J Autoimmune Dis. 2006 Oct 5;3:5.
Related citations
Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigó M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F.
Ann N Y Acad Sci. 2007 Sep;1110:578-89.
Cytokine profiles during infliximab monotherapy in psoriatic arthritis.
Mastroianni A, Minutilli E, Mussi A, Bordignon V, Trento E, D'Agosto G, Cordiali-Fei P, Berardesca E.
Br J Dermatol. 2005 Sep;153(3):531-6.
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ.
J Am Acad Dermatol. 2006 Jun;54(6):1003-12. Epub 2006 Mar 20.
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MB, Bos JD, Tak PP.
Arthritis Res Ther. 2004;6(4):R326-34. Epub 2004 May 26.
Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Giuliano A, Sabato S, Stramazzotti D, Gulini E, Dusi D, De Blasio S, Fabris G, Offidani A.
Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):371-7.
Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
Markham T, Mathews C, Rogers S, Mullan R, Bresnihan B, Fitzgerald O, Veale DJ, Fearon U.
Br J Dermatol. 2006 Dec;155(6):1191-6.
Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate.
Ogilvie AL, Antoni C, Dechant C, Manger B, Kalden JR, Schuler G, Lüftl M.
Br J Dermatol. 2001 Mar;144(3):587-9.
Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.
Ogilvie AL, Lüftl M, Antoni C, Schuler G, Kalden JR, Lorenz HM.
Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):271-8.
Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial.
Bhushan M, Bleiker TO, Ballsdon AE, Allen MH, Sopwith M, Robinson MK, Clarke C, Weller RP, Graham-Brown RA, Keefe M, Barker JN, Griffiths CE.
Br J Dermatol. 2002 May;146(5):824-31.
Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
Serwin AB, Sokolowska M, Chodynicka B.
Photodermatol Photoimmunol Photomed. 2007 Aug;23(4):130-4.
Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.
Victor FC, Gottlieb AB, Menter A.
Clin Dermatol. 2003 Sep-Oct;21(5):392-7. Review.
Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D, Kanno H, Yoshida A, Kurose A, Akasaka T, Sawai T.
Br J Dermatol. 2007 Aug;157(2):259-65. Epub 2007 Jun 26.
Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis.
Kawaguchi M, Mitsuhashi Y, Kondo S.
Br J Dermatol. 2005 May;152(5):915-9.
Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Flisiak I, Myśliwiec H, Chodynicka B.
J Eur Acad Dermatol Venereol. 2005 Jul;19(4):418-21.
Correlation of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapy.
Carducci M, Mussi A, Bonifati C, Tomaselli R, Onorati MT, Trento E, Ameglio F.
J Dermatol. 1995 Jul;22(7):475-9.
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G.
Int J Mol Med. 2006 Sep;18(3):415-23.
VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study.
Simonetti O, Lucarini G, Goteri G, Zizzi A, Biagini G, Lo Muzio L, Offidani A.
Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):751-60.
Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients.
Serwin AB, Mysliwiec H, Hukalowicz K, Porebski P, Borawska M, Chodynicka B.
Nutrition. 2003 Oct;19(10):847-50.
[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH, Huang F, Deng XH, Zhang JL, Zhang LY, Guo JH, Liang DF, Wang LS, Zhang YM.
Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2451-4. Chinese.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on